Carl Decicco Foghorn Therapeutics Inc. (FHTX) insider trading activity
Carl Decicco is Chief Scientific Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 362,707 shares of FHTX, which is worth approximately $1.75 Million. The most recent transaction as insider was on Dec 09, 2021, when has been sold 104,310 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $388,033. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
363K
0%
3M change
0%
12M change
Total Value Held
$1.75 Million
CARL DECICCO Transaction History
CD
Carl Decicco
Chief Scientific Officer
Cambridge, MA